Chenyang Xu

915 total citations
45 papers, 662 citations indexed

About

Chenyang Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chenyang Xu has authored 45 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chenyang Xu's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Chenyang Xu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Chenyang Xu collaborates with scholars based in China, Japan and United Kingdom. Chenyang Xu's co-authors include Tamar Megidish, Zezhong Mou, Xinan Chen, Yuxi Ou, Chen Yang, Siqi Wu, Xiyu Dai, Haowen Jiang, Yiling Chen and Honglin Liu and has published in prestigious journals such as Journal of Biological Chemistry, The Science of The Total Environment and Water Research.

In The Last Decade

Chenyang Xu

41 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenyang Xu China 13 430 274 101 79 79 45 662
Anna Paola Carreca Italy 12 326 0.8× 236 0.9× 111 1.1× 106 1.3× 48 0.6× 28 602
Leliang Zheng China 8 482 1.1× 360 1.3× 103 1.0× 82 1.0× 80 1.0× 13 645
Shaoyan Liu China 12 371 0.9× 218 0.8× 113 1.1× 53 0.7× 44 0.6× 43 657
Xinyuan Zhao China 17 522 1.2× 312 1.1× 86 0.9× 78 1.0× 42 0.5× 36 749
Xinxing Zhu China 15 513 1.2× 299 1.1× 60 0.6× 75 0.9× 75 0.9× 36 747
Annamaria Massa Italy 13 403 0.9× 243 0.9× 156 1.5× 96 1.2× 53 0.7× 22 776
Yue Yang China 14 260 0.6× 183 0.7× 134 1.3× 79 1.0× 72 0.9× 74 723
Fei Miao China 15 314 0.7× 239 0.9× 131 1.3× 107 1.4× 47 0.6× 61 776
Lianbi Zhao China 10 691 1.6× 337 1.2× 43 0.4× 37 0.5× 98 1.2× 17 825

Countries citing papers authored by Chenyang Xu

Since Specialization
Citations

This map shows the geographic impact of Chenyang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyang Xu more than expected).

Fields of papers citing papers by Chenyang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenyang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyang Xu. The network helps show where Chenyang Xu may publish in the future.

Co-authorship network of co-authors of Chenyang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenyang Xu. A scholar is included among the top collaborators of Chenyang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenyang Xu. Chenyang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Qiankun, et al.. (2025). A case of massive hematoma: reflections on hypermobile Ehlers-Danlos syndrome. Frontiers in Medicine. 12. 1514349–1514349.
3.
Liang, Zhiting, et al.. (2024). Deciphering the virucidal potential of hydroxyl radical during ozonation: Implications for waterborne virus inactivation. Water Research. 272. 122982–122982. 4 indexed citations
4.
Su, Wenhua, Chenyang Xu, Yiyan Fei, et al.. (2024). Non‐invasive screening of bladder cancer using digital microfluidics and FLIM technology combined with deep learning. Journal of Biophotonics. 17(9). e202400192–e202400192. 1 indexed citations
5.
Xu, Zhiyuan, et al.. (2024). HTR3A Promotes Non-small Cell Lung Cancer Through the FOXH1/Wnt3A Signaling Pathway. Biochemical Genetics. 63(4). 3554–3566. 2 indexed citations
6.
7.
Yang, Shaolin, et al.. (2024). Evaluating approach uncertainties of quantitative detection of SARS-CoV-2 in wastewater: Concentration, extraction and amplification. The Science of The Total Environment. 951. 175285–175285. 3 indexed citations
8.
Ren, Yunzhao R., Qinchuan Wang, Chenyang Xu, et al.. (2024). Combining Classic and Novel Neutrophil-Related Biomarkers to Identify Non-Small-Cell Lung Cancer. Cancers. 16(3). 513–513. 3 indexed citations
9.
Mou, Zezhong, Yiling Chen, Yun Hu, et al.. (2024). Icaritin inhibits the progression of urothelial cancer by suppressing PADI2-mediated neutrophil infiltration and neutrophil extracellular trap formation. Acta Pharmaceutica Sinica B. 14(9). 3916–3930. 10 indexed citations
10.
Ye, Fangdie, Yingchun Liang, Chenyang Xu, et al.. (2023). Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study. Frontiers in Nutrition. 10. 992608–992608. 4 indexed citations
11.
Yang, Chen, Lujia Zou, Yun Hu, et al.. (2023). Combining MTI-31 with RAD001 inhibits tumor growth and invasion of kidney cancer by activating autophagy. Journal of Applied Genetics. 65(1). 103–112. 1 indexed citations
12.
Yang, Chen, Lujia Zou, Yun Hu, et al.. (2023). Protective Autophagy Attenuates the Cytotoxicity of MTI-31 in Renal Cancer Cells by Activating the ERK Pathway. Applied Biochemistry and Biotechnology. 196(4). 2233–2245. 2 indexed citations
13.
Xu, Chenyang, Tianwei Guo, Shenghua Zhan, et al.. (2023). Clinical significance of CD155 expression and correlation with cellular components of tumor microenvironment in gastric adenocarcinoma. Frontiers in Immunology. 14. 1173524–1173524. 6 indexed citations
14.
Xie, Ning, et al.. (2022). Characterization of a prognostic model for lung squamous cell carcinoma based on eight stemness index-related genes. BMC Pulmonary Medicine. 22(1). 224–224. 7 indexed citations
15.
Xu, Chenyang, Takeo Minaguchi, Nan Qi, et al.. (2022). Differential roles of the Wip1–p38–p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas. World Journal of Surgical Oncology. 20(1). 139–139. 1 indexed citations
16.
Lu, Xinhua, Chenyang Xu, Chunya Lu, et al.. (2021). Piperlongumine inhibits the growth of non-small cell lung cancer cells via the miR-34b-3p/TGFBR1 pathway. BMC Complementary Medicine and Therapies. 21(1). 15–15. 16 indexed citations
17.
Zhang, Shuang, Takeo Minaguchi, Chenyang Xu, et al.. (2020). PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas. BMC Cancer. 20(1). 127–127. 34 indexed citations
18.
Minaguchi, Takeo, Azusa Akiyama, Shilin Liu, et al.. (2018). Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin. Medicine. 97(31). e11392–e11392. 18 indexed citations
19.
Xu, Chenyang, et al.. (2017). Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells. Biomedicine & Pharmacotherapy. 95. 1504–1513. 76 indexed citations
20.
Megidish, Tamar, et al.. (2002). Activation of p53 by Protein Inhibitor of Activated Stat1 (PIAS1). Journal of Biological Chemistry. 277(10). 8255–8259. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Paola Carreca Breakdown of academic impact, for papers by Leliang Zheng Breakdown of academic impact, for papers by Shaoyan Liu Breakdown of academic impact, for papers by Xinyuan Zhao Breakdown of academic impact, for papers by Xinxing Zhu Breakdown of academic impact, for papers by Annamaria Massa Breakdown of academic impact, for papers by Yue Yang Breakdown of academic impact, for papers by Fei Miao Breakdown of academic impact, for papers by Lianbi Zhao
Rankless by CCL
2026